Northern Trust Corp Zentalis Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

$690 Billion
Q4 2024

A detailed history of Northern Trust Corp transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 484,738 shares of ZNTL stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

484,738

Previous 474,225 2.22%

Holding current value

$1.12 Million

Previous $1.74 Million 15.63%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$2.7 - $4.03 $28,385 - $42,367	10,513 Added 2.22%	484,738 $1.47 Million
Q3 2024 Nov 13, 2024	SELL	$2.9 - $4.57 $61,018 - $96,157	-21,041 Reduced 4.25%	474,225 $1.74 Million
Q2 2024 Aug 14, 2024	SELL	$4.09 - $16.13 $116,303 - $458,672	-28,436 Reduced 5.43%	495,266 $2.03 Million
Q1 2024 May 14, 2024	SELL	$10.83 - $16.49 $68,239 - $103,903	-6,301 Reduced 1.19%	523,702 $8.25 Million
Q4 2023 Feb 13, 2024	SELL	$9.84 - $20.13 $105,474 - $215,773	-10,719 Reduced 1.98%	530,003 $8.03 Million
Q3 2023 Nov 13, 2023	BUY	$19.63 - $28.29 $1.22 Million - $1.75 Million	61,919 Added 12.93%	540,722 $10.8 Million
Q2 2023 Aug 11, 2023	BUY	$17.41 - $30.05 $904,136 - $1.56 Million	51,932 Added 12.17%	478,803 $13.5 Million
Q1 2023 May 15, 2023	BUY	$16.14 - $24.94 $110,187 - $170,265	6,827 Added 1.63%	426,871 $7.34 Million
Q4 2022 Feb 13, 2023	BUY	$18.07 - $25.6 $54,246 - $76,851	3,002 Added 0.72%	420,044 $8.46 Million
Q3 2022 Nov 14, 2022	BUY	$20.23 - $31.73 $872,762 - $1.37 Million	43,142 Added 11.54%	417,042 $9.03 Million
Q2 2022 Aug 12, 2022	BUY	$17.91 - $52.25 $620,921 - $1.81 Million	34,669 Added 10.22%	373,900 $10.5 Million
Q1 2022 May 13, 2022	SELL	$41.58 - $80.89 $438,003 - $852,095	-10,534 Reduced 3.01%	339,231 $15.7 Million
Q4 2021 Feb 08, 2022	BUY	$66.92 - $84.79 $95,896 - $121,504	1,433 Added 0.41%	349,765 $29.4 Million
Q3 2021 Nov 15, 2021	BUY	$46.83 - $73.5 $1.92 Million - $3.01 Million	41,002 Added 13.34%	348,332 $23.2 Million
Q2 2021 Aug 13, 2021	BUY	$37.41 - $62.25 $898,101 - $1.49 Million	24,007 Added 8.47%	307,330 $16.4 Million
Q1 2021 May 12, 2021	BUY	$35.69 - $52.72 $31,442 - $46,446	881 Added 0.31%	283,323 $12.3 Million
Q4 2020 Feb 11, 2021	BUY	$31.71 - $57.97 $4.39 Million - $8.03 Million	138,550 Added 96.29%	282,442 $14.7 Million
Q3 2020 Nov 16, 2020	BUY	$27.03 - $47.97 $306,952 - $544,747	11,356 Added 8.57%	143,892 $4.7 Million
Q2 2020 Aug 14, 2020	BUY	$23.2 - $54.8 $3.07 Million - $7.26 Million	132,536 New	132,536 $6.36 Million

Others Institutions Holding ZNTL

# of Institutions

147

Shares Held

65.3M

Call Options Held

43.2K

Put Options Held

21.7K

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $132M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Zentalis Pharmaceuticals, Inc. Transaction History